Trial Profile
A Study to Evaluate the Efficacy and Safety of Intravitreal Ranibizumab in Patients With Pseudophakic Cystoid Macular Edema
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 May 2016
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Retinal oedema
- Focus Adverse reactions; Therapeutic Use
- 17 May 2016 New trial record